IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Frazier Management LLC

Q3 2018 Holdings

Filed 2018-11-14 | 16 holdings | $28.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Collegium Pharmaceutical Inc(COLL)COM19459J104$27.8M1,887,33298.2%
Anaptysbio Inc(ANAB)COM032724106$231.1K2,316,4470.8%
Aptinyx IncCOM03836N103$92.4K3,190,0790.3%
Allena Pharmaceuticals Inc(ALNAEUR)COM018119107$35.8K3,330,3730.1%
Gritstone Oncology Inc(2JQ)COM39868T105$29.4K2,061,7620.1%
Iovance Biotherapeutics Inc(IOVA)COM462260100$24.6K2,188,3310.1%
Entasis Therapeutics Hldgs ICOM293614103$14.7K1,349,9530.1%
Alpine Immune Sciences Inc(NVLSEUR)COM02083G100$13.9K2,199,0110.0%
Sierra Oncology IncCOM82640U107$13.8K8,112,1210.0%
Synlogic IncCOM87166L100$12.3K865,4070.0%
Nabriva Therapeutics PLCSHSG63637105$11.5K4,256,5260.0%
Krystal Biotech Inc(KRYS)COM501147102$11.0K625,0000.0%
Iterum Therapeutics PLCSHSG6333L101$10.3K1,538,3160.0%
Bellicum Pharmaceuticals IncCOM079481107$6.5K1,051,4410.0%
Cidara Therapeutics IncCOM171757107$5.8K1,312,2580.0%
Kezar Life Sciences IncCOM49372L100$5.4K250,0000.0%